Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells

Journal of Medical Virology

Volumn 56, Issue 2, 1998, Pages 112-117

  Schlaak, Jörg F ^a   Pitz, Tanja ^a   Löhr, Hanns F ^a   Meyer Zum Büschenfelde, Karl Hermann ^a   Gerken, Guido ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Accessory cells; Cellular immune defect; Proinflammatory cytokines

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; POKEWEED MITOGEN; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN; VIRUS RNA;

ACCESSORY CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; MONONUCLEAR CELL; SEROTYPING;

CYTOKINES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; RNA, VIRAL; TH1 CELLS;

EID: 0031682240     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199810)56:2<112::AID-JMV2>3.0.CO;2-B     Document Type: Article

References (26)

1. Alter HJ (1992): New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology 15:350-353.
2. Bach N, Thung SN, Schaffner F (1992): The histological features of chronic hepatitic C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15:572-577.
3. Becker JC, Brocker EB (1994): Prevention of anergy induction in cloned T cells by interleukin 12. Exp. Dermatol. 3:283-289.
4. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, Pape GR (1995): Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
5. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, Missale G, Marin MG, Fiaccadori F (1994): T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286-295.
6. Freni MA, Artuso D, Gerken G, Spanti C, Marafioti T, Alessi N, Spadaro A, Ajello A, Ferrau O (1995): Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology 22:389-394.
7. Gazzinelli RT, Bala S, Stevens R, Baseler M, Wahl L, Kovacs J, Sher A (1995): HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. Journal of Immunology 155: 1565-1574.
8. Gerken G, Knolle P, Jakobs S, Meyer zum Bueschenfelde KH (1997): Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment. Archives of Virology 142:459-464.
9. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 21:632-638.
10. Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G (1992): Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. Journal of Clinical Investigation 90:262-266.
11. Koff RS, Dienstag JL (1995): Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Seminars in Liver Disease 15:101-109.
12. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD (1993): Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. Journal of Virology 67:7522-7532.
13. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, Houghton M, Walker BD (1995): HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. Journal of Clinical Investigation 96:2311-2321.
14. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992): Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. Journal of Immunology 149:3339-3344.
15. Landay AL, Clerici M, Hashemi F, Kessler H, Berzofsky JA, Shearer GM (1996): In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10. Journal of Infectious Diseases 173: 1085-1091.
16. Lechmann M, Langhans B, Bär S, Woitas R, Leifeld L, Ihlenfeldt HG, Jung G, Effenberger W, Sauerbruch T, Spengler U (1996). Deficient secretion of Th1 cytokines in patients with chronic hepatitis C. Hepatology 24(4, Pt. 2):266A.
17. Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, Chu CM (1995): T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 22:1368-1373.
18. Löhr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Bueschenfelde KH (1994a): Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14:161-166.
19. + T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. Liver 16: 174-182.
20. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993): Natural killer cell stimulatory factor (interleukin 12 [IL-12] induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. Journal of Experimental Medicine 177:1199-1204.
21. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM (1992): The pathology of hepatitis C. Hepatology 15:567-571.
22. Schlaak JF, Loehr H, Gallati H, Meyer zum Bueschenfelde KH, Fleischer B (1993): Analysis of the in vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clinical and Experimental Immunology 94:168-173.
23. + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. European Journal of Immunology 24:793-798.
24. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS (1993): Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology 74:2391-2399.
25. Uherova P, Connick E, MaWhinney S, Schlichtemeier R, Schooley RT, Kuritzkes DR (1996): In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1. Journal of Infectious Diseases 174:483-489.
26. Woitas RP, Lechmann M, Langhans B, Bär S, Ihlenfeldt HG, Jung G, Sauerbruch T, Spengler U (1996) Cytokine response to hepatitis C virus core peptides in patients with chronic hepatitis C infection and healthy anti-HCV seropositives. Hepatology 24(4, Pt. 2):266A.